Live Oak Private Wealth LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 24,791 shares of the healthcare conglomerate’s stock after selling 39 shares during the quarter. UnitedHealth Group accounts for approximately 2.1% of Live Oak Private Wealth LLC’s investment portfolio, making the stock its 9th biggest position. Live Oak Private Wealth LLC’s holdings in UnitedHealth Group were worth $12,541,000 at the end of the most recent quarter.
Several other large investors have also bought and sold shares of the business. Genesee Capital Advisors LLC increased its holdings in UnitedHealth Group by 1.9% in the 3rd quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock worth $579,000 after purchasing an additional 18 shares in the last quarter. Jmac Enterprises LLC raised its holdings in UnitedHealth Group by 2.2% in the 3rd quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock valued at $481,000 after buying an additional 18 shares during the last quarter. Powers Advisory Group LLC increased its position in UnitedHealth Group by 4.8% in the 3rd quarter. Powers Advisory Group LLC now owns 418 shares of the healthcare conglomerate’s stock valued at $244,000 after acquiring an additional 19 shares during the period. Wallace Capital Management Inc. grew its stake in shares of UnitedHealth Group by 0.9% in the third quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock worth $1,239,000 after purchasing an additional 19 shares during the last quarter. Finally, Western Pacific Wealth Management LP lifted its holdings in UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after buying an additional 19 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.
UnitedHealth Group Stock Performance
UNH stock opened at $529.71 on Friday. The business has a 50 day moving average of $532.43 and a 200-day moving average of $564.77. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The firm has a market cap of $487.48 billion, a PE ratio of 34.17, a P/E/G ratio of 1.48 and a beta of 0.61.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on the company. Barclays cut their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Bank of America lowered their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Truist Financial cut their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Royal Bank of Canada cut their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Finally, Oppenheimer increased their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and an average price target of $629.32.
Check Out Our Latest Stock Report on UNH
Insider Activity
In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.33% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- Stock Analyst Ratings and Canadian Analyst Ratings
- Uber’s Business, Cash Flow, and AI are Why it Will Set a New High
- What Makes a Stock a Good Dividend Stock?
- Weak Guidance from Bristol-Myers Could Be Creating an Opportunity
- How Can Investors Benefit From After-Hours Trading
- These are the 3 Stocks Most Likely to Split in 2025
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.